A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma.
Chen J, Oberheim Bush NA, Grabowsky JA, Kline C, Kroetz DL, Taylor JW, Villanueva-Meyer J, Molinaro AM, de Groot JF, Butowski NA, Tedesco M, Rabbitt J, Phillips JJ, Hervey-Jumper S, Aghi MK, Berger MS, Chang EF, Chang SM, Solomon DA, Clarke JL.
Chen J, et al.
Clin Cancer Res. 2026 Feb 6. doi: 10.1158/1078-0432.CCR-25-4080. Online ahead of print.
Clin Cancer Res. 2026.
PMID: 41649856